Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
9 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
For best results when printing this announcement, please click on link below: RNS Number: 0622W BioPharma Credit PLC 24 September 2026 24 September 2026 BIOPHARMA CREDIT PLC ("BPCR" or "the Company") HALF YEAR REPORT FOR THE YEAR ENDED 30 JUNE 2026 BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt inv
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings
U.S. equities opened August with a broad-based relief rally Monday as crude oil tumbled and Treasury yields retreated from 18-month highs, after President Donald Trump called off a planned military strike on Iran over the weekend and said negotiations would resume. West Texas Intermediate crude sank 5.9% to $79.69 a ba
BMY shares decline
Bristol-Myers Squibb Co. (NYSE: BMY ) shares are up on Thursday as the company reported its second-quarter financial results for 2026. • Bristol-Myers Squibb stock is showing upward movement. Why are BMY shares climbing? The U.S. large pharma company reported adjusted earnings of $2.04, beating the Wall Street estimate
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 200 points on Thursday. The Dow traded up 0.40% to 51,801.63 while the NASDAQ surged 2.08% to 24,952.56. The S&P 500 also rose, gaining, 0.89% to 7,381.26. Leading and Lagging Sectors Information technology shares jumped by 4.4
Earnings are back in the driver’s seat on Thursday, with a -selected slate that ranges from regulated utilities to mega-cap tech and payments. With guidance and segment commentary often moving stocks as much as the headline numbers, the options market offers a real-time read on how much volatility traders are bracing f
BMY Earnings pre-market tomorrow: qtr EPS est $1.59 (high $1.65/low $1.48), 30-day avg EPS revision -1.6% (3 analyst(s) revised up, 11 down), qtr revs est $11.75B; FY EPS est $6.34, FY revs est $47.47B; short interest 2.2%; implied move +/-3.7%; consensus rec Hold; consensus PT $63; call is 7/30/26 8:15 AM
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings